Definition

A bispecific monoclonal antibody directed against as of yet unknown targets, with potential antineoplastic activity. Upon administration, bispecific monoclonal antibody ASP2074 may, through as of yet unelucidated mechanisms of action, enhance cellular immune responses against susceptible tumor cells, resulting in increased tumor cell lysis.